Surrogate end points for prostate cancer: what is prostate-specific antigen telling us?

J Natl Cancer Inst. 2003 Sep 17;95(18):1352-3. doi: 10.1093/jnci/djg071.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Biomarkers, Tumor / blood*
  • Clinical Trials as Topic
  • Humans
  • Male
  • Prostate-Specific Antigen / blood*
  • Prostatic Neoplasms / immunology*
  • Prostatic Neoplasms / therapy*
  • Time Factors
  • Treatment Outcome

Substances

  • Biomarkers, Tumor
  • Prostate-Specific Antigen